Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000058469 | SCV000055302 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000041608 | SCV000065304 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | Pro656Leu in exon 13 of SCN5A: This variant is not expected to have clinical sig nificance because it has been identified in 0.4% (14/3728) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs41313681). Pro656Leu in exon 13 of SCN5A (r s41313681; allele frequency = 0.4%, 14/3728) ** |
Eurofins Ntd Llc |
RCV000041608 | SCV000225947 | benign | not specified | 2015-06-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000058469 | SCV000235394 | likely benign | not provided | 2020-10-06 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 19841300, 20129283, 15851227, 25854863, 23861362, 26746457) |
Invitae | RCV000058469 | SCV000557117 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000058469 | SCV000700022 | likely benign | not provided | 2016-05-23 | criteria provided, single submitter | clinical testing | Variant summary: The SCN5A c.1967C>T (p.Pro656Leu) variant involves the alteration of a mildly conserved nucleotide. 4/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 48/121480 control chromosomes at a frequency of 0.0003951, which is approximately 4 times the estimated maximal expected allele frequency of a pathogenic SCN5A variant (0.0001), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications, nor evaluated for functional impact by in vivo/vitro studies. However, it has been reported being detected in the control cohorts, further supporting benign classification (Ackerman_2004, Kapa_2009, and Kapplinger_2010). In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as likely benign/benign. Taken together, this variant is classified as Likely Benign until more information becomes available. |
Color Diagnostics, |
RCV001841597 | SCV000913815 | likely benign | Cardiac arrhythmia | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001147411 | SCV001308234 | benign | Dilated cardiomyopathy 1E | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001147412 | SCV001308235 | benign | Progressive familial heart block, type 1A | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001147413 | SCV001308236 | benign | Sick sinus syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001147414 | SCV001308237 | likely benign | Brugada syndrome 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV001147415 | SCV001308238 | benign | Long QT syndrome 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001147416 | SCV001308239 | likely benign | Ventricular fibrillation, paroxysmal familial, type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Prevention |
RCV004541213 | SCV004775977 | likely benign | SCN5A-related disorder | 2021-01-17 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Ambry Genetics | RCV004017337 | SCV004849274 | likely benign | Cardiovascular phenotype | 2018-10-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Cardiovascular Biomedical Research Unit, |
RCV000058469 | SCV000089989 | not provided | not provided | no assertion provided | literature only | This variant has been reported in the following publications (PMID:19841300;PMID:20129283). |